China online pharmaceutical trading site raises $16m
Yaoshibang, a Chinese B2B pharmaceutical trading platform, has raised a RMB110 million ($16 million) Series B round co-led by Shenzhen-based Green Pine Capital Partners and Fosun Group.
Existing investors Co-Power Capital and Ivy Capital also participated in the round. Operated by Guangzhou Speedroad Medical Information, Yaoshibang was launched in 2015 by a former executive at Chinese...
More on Greater China
Latest News
China-US tensions: Foggy flashpoints
Rhetoric shaping the debate over China's ambitions to become the prime mover in global technology - and what the US could do in response - reflects the geopolitical significance of the issue. Private equity investors are not immune to its impact
Novo Tellus buys stake in data center equipment supplier
Novo Tellus Capital Partners has invested S$12 million ($8.8 million) in Procurri, a Singapore-listed provider of IT services and data center equipment.
Australia's Anacacia completes final exit from debut fund
Australia’s Anacacia Capital has realized the final exit from its debut fund with the sale of its majority stake in workplace equipment provider RIS Safety to domestic investor Bricktop Group.
Bain buys Chinese data center services business
Bain Capital has acquired a majority interest in the data center construction and maintenance division of Shenzhen-listed NetScience Technology for RMB990 million ($147 million).